Stride Inc Shares Surpass Analyst Target Price: What Analysts Think
Recently, Stride Inc (Symbol: LRN) shares have traded above the average analyst 12-month target price of $126.00, currently priced at $127.13 per share. When a stock reaches its target price, analysts usually have two choices: either downgrade the stock based on valuation or raise the target price. Analyst responses may hinge on fundamental developments driving the stock price higher; if the outlook improves for the company, an upward adjustment may be warranted.
Within the Zacks coverage universe for Stride Inc, there are five analysts contributing to the average target. It is important to note that this average represents a mathematical midpoint. While some analysts set lower limits, with one target as low as $94.00, others have established a target as high as $145.00. The standard deviation among these targets is $20.772.
The primary purpose of analyzing the average LRN target price is to leverage a “wisdom of crowds” approach. This method combines insights from multiple analysts rather than relying on the opinion of a single expert. With LRN now exceeding the average target price of $126.00 per share, investors might consider evaluating the company’s potential further. Questions arise: Is $126.00 merely a waypoint toward an even higher price target, or has the valuation reached a level that prompts re-evaluation of positions? Below is a table summarizing the current sentiment among analysts covering Stride Inc:
Recent LRN Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong buy ratings: | 4 | 4 | 4 | 4 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.67 | 1.67 | 1.67 | 1.67 |
The average rating in the table ranges from 1 to 5, where 1 indicates a Strong Buy and 5 indicates a Strong Sell. This article utilizes data from Zacks Investment Research, sourced via Quandl.com. For the latest insights from Zacks, access their research report on LRN—available for free.
The Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
• Highest Yielding BDCs
• CLNC market cap history
• Top Ten Hedge Funds Holding DGBP
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.